Painless gastrointestinal endoscopy
Conditions
Interventions
Young male group:The fixed dose of sufentanil was 0.1 µ g/kg, the initial dose of cyclopofol was 0.4 mg/kg, and the dose gradient was 0.05 mg/kg When MOAA/S is less than or equal to 1 min, the dose of
If gastroscope implantation reaction occurs, a dose gradient is up-regulated
Young Female Category:The fixed dose of sufentanil was 0.1 µ g/kg, the initial dose of cyclopofol was 0.4 mg/kg, and the dose gradient was 0.05 mg/kg When MOAA/S is less than or equal to 1 min, the do
Middle-aged male group:The fixed dose of sufentanil was 0.1 µ g/kg, the initial dose of cyclopofol was 0.4 mg/kg, and the dose gradient was 0.05 mg/kg When MOAA/S is less than or equal to 1 min, the d
Middle-aged female group:The fixed dose of suf
Sponsors
Huludao Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) ASA grade I.-II., BMI 18-25 kg/m2, gender is not limited. (2) Meet the indications for painless gastrointestinal endoscopy. (3) Aware of the purpose of this research and have signed a written consent form.
Exclusion criteria
Exclusion criteria: (1) Those who are allergic to or contraindicated to opioids, cyclopofol and their drug components. (2) Patients with a history of severe cardiopulmonary diseases, a history of psychiatric or neurological diseases, and severe muscle weakness. (3) Those who are unable to obtain informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ED50;ED95; | — |
Secondary
| Measure | Time frame |
|---|---|
| Presence or absence of body movement;Blood pressure;heart rate;Oxygen saturation; | — |
Countries
China
Contacts
Public ContactDing Baochun
Huludao Central Hospital, Liaoning Province
Outcome results
None listed